The Financial Times reported that Bon Secours Mercy Health is in advanced discussions to acquire a majority stake in Surgery Partners.
The proposed transaction would value Surgery Partners at approximately $6 billion including debt, with an indicated acquisition price of around $20 per share, compared with its previous closing price of $15.90.
Bain Capital would reportedly retain its approximately 40% ownership interest.
No definitive acquisition agreement had been publicly confirmed at the reporting cutoff. The reported transaction terms remain subject to verification. Financial Times
Sources: Financial Times — October 25 acquisition report · Reuters — October 25 confirmation of reported discussions
Why it matters strategically
The transaction would represent a substantial investment in outpatient surgical infrastructure.
Ambulatory surgery centers increasingly compete with conventional hospitals for procedures that can be performed safely without extended inpatient admission.
However, the economic attractiveness of these facilities depends on several variables.
Procedure mix, physician relationships, reimbursement rates, facility utilization, and labor costs can produce materially different financial outcomes.
Acquiring a large network does not automatically create favorable economics.
The value depends on whether the acquirer can improve operational performance and capture additional patient volumes without increasing costs disproportionately.
